Advance Search
CHENG Kewei, FANG Xiaoming, WU Yuying. Analysis in correlations between prognosis and three serum indexes in patients with advanced lung adenocarcinoma with chemotherapy[J]. Journal of Clinical Medicine in Practice, 2020, 24(24): 10-12,16. DOI: 10.7619/jcmp.202024003
Citation: CHENG Kewei, FANG Xiaoming, WU Yuying. Analysis in correlations between prognosis and three serum indexes in patients with advanced lung adenocarcinoma with chemotherapy[J]. Journal of Clinical Medicine in Practice, 2020, 24(24): 10-12,16. DOI: 10.7619/jcmp.202024003
shu

Analysis in correlations between prognosis and three serum indexes in patients with advanced lung adenocarcinoma with chemotherapy

  • Department of Respiratory and Critical Care Medicine, Changzhou Second People's Hospital Affiliated to Nanjing Medical University, Changzhou, Jiangsu, 210029

More Information
  • Received Date: November 11, 2020
  • Available Online: December 29, 2020
    Graphical Abstract
    • Abstract
  • Objective To analyze correlations between prognosis and serum carcinoembryonic antigen(CEA), lactate dehydrogenase(LHD), thyroid transcription factor-1(TTF-1)levels in patients with advanced lung adenocarcinoma undergoing chemotherapy. Methods A total of 62 patients with advanced lung adenocarcinoma undergoing chemotherapy were selected as research objects, their serum CEA, LHD, TTF-1 levels were detected, the relationships between serum CEA, LHD, TTF-1 levels and prognosis in patients with advanced lung adenocarcinoma undergoing chemotherapy were analyzed, and the conditions of survival and death of patients within 2 years of follow-up were explored. Results The serum CEA, LHD, and TTF-1 levels of the death group were higher than those of the survival group, and the differences were statistically significant(P<0.05). Logistic regression analysis showed that higher levels of serum CEA, LHD, and TTF-1 might be risk factors leading to death in patients with advanced lung adenocarcinoma undergoing chemotherapy(OR>1, P<0.01). The results showed that area under the curve(AUC)of the prognosis predicted by the levels of serum CEA, LHD, TTF-1 in advanced lung adenocarcinoma patients was above 0.7, which indicated that all the three indicators were of great value in predicting the disease. Conclusion Serum CEA, LHD, and TTF-1 may be involved in the occurrence and development of advanced lung adenocarcinoma, and are closely related to the prognosis of chemotherapy patients. Clinically, the prognosis of patients with advanced lung adenocarcinoma undergoing chemotherapy can be assessed by detecting serum CEA, LHD, and TTF-1 levels.
    • FullText(HTML)
    • References (15)
  • 黄芳, 姜达, 李颖, 等. 晚期肺腺癌化疗方案的优化[J]. 肿瘤防治研究, 2015, 42(7): 687-692.
    刘月平, 刘俊英, 陈砚凝, 等. 不同组织学分型肺腺癌患者的临床特征及预后影响因素研究[J]. 中国全科医学, 2016, 19(11): 1272-1275.
    王黎明, 刘洋, 许顺. Ⅲ期非小细胞肺癌手术治疗患者预后因素分析[J]. 中华肿瘤防治杂志, 2017, 24(21): 1534-1538.
    唐伟娜, 杨瑞青, 刘斌, 等. 血清CEA和LDH对肺腺癌靶向治疗疗效和预后的评价作用[J]. 临床肺科杂志, 2016, 21(1): 29-32.
    ZHANG Y L, WANG R, LI Y, et al. Negative thyroid transcription factor 1 expression defines an unfavorable subgroup of lung adenocarcinomas[J]. J Thorac Oncol, 2015, 10(10): 1444-1450.
    SHOLL L M. Biomarkers in lung adenocarcinoma: a decade of progress[J]. Arch Pathol Lab Med, 2015, 139(4): 469-480.
    SON S M, HAN H S, AN J Y, et al. Diagnostic performance of CD66c in lung adenocarcinoma-associated malignant pleural effusion: comparison with CEA, CA 19-9, and CYFRA 21-1[J]. Pathology, 2015, 47(2): 123-129.
    赵静, 武二伟, 邢爱民, 等. 119例局部晚期非小细胞肺癌放化疗后预后分析[J]. 临床肺科杂志, 2017, 22(8): 1481-1485.
    卢畅, 申淑景, 毛玉焕, 等. CEA, CYFRA21-1, NSE水平与EGFR突变的晚期肺腺癌患者临床疗效的相关性[J]. 肿瘤防治研究, 2017, 44(7): 485-488.
    陈从华, 明炜, 龚顺松, 等. CEA、NSE及CYFRA21-1对老年非小细胞肺癌患者手术预后判断的价值[J]. 河北医药, 2017, 39(5): 675-677

    , 682.
    马美丽, 韩宝惠. 晚期肺腺癌血浆与组织表皮生长因子受体基因突变检测及预后分析[J]. 世界临床药物, 2017, 38(3): 162-168.
    刘剑, 吉浩明, 刘春桂, 等. 血清CEA、LDH对肺腺癌靶向治疗的临床疗效及预后的预测价值[J]. 实用癌症杂志, 2017, 32(2): 178-180.
    王建玲, 杨嘉, 宋玉良. 晚期肺癌患者化疗前后血清LDH水平变化对化疗疗效及预后的预测[J]. 河北医药, 2016, 38(3): 366-368.
    张旭刚, 李维青, 高颖, 等. 肺腺癌组织中TTF-1表达变化及其与EGFR基因突变、患者预后的关系[J]. 山东医药, 2017, 57(31): 44-46.
    沈维敏, 许佳毅, 唐曦. 原发性肺腺癌alpha-B-crystallin、TTF-1、NapsinA表达研究[J]. 临床和实验医学杂志, 2016, 15(18): 1800-1803.
    • Related Articles

  • Related Articles

    [1]LI Yun, ZHONG Wen, YANG Fan, SHI Wenhua, CHEN Dong, LU Jun, WANG Mei. Analysis in clinical characteristics and risk factors of asparaginase-associated pancreatitis in children[J]. Journal of Clinical Medicine in Practice, 2022, 26(12): 65-68, 75. DOI: 10.7619/jcmp.20220605
    [2]YANG Jiao, CHEN Song. Clinical efficacy of gemcitabine, cisplatin and gefitinib in combination in the treatment of advanced non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(19): 63-66. DOI: 10.7619/jcmp.202019018
    [3]FENG Yongjun, CHEN Dongxiang, LUO Fei, XIANG Jinjian, HU Xiaomiao, XIAO Baolai, LI Mingzhong. Effects of oxaliplatin combined with capecitabine on T lymphocyte immunity status and tumor factors in elderly patients with radical gastrectomy for gastric cancer[J]. Journal of Clinical Medicine in Practice, 2018, (13): 56-59. DOI: 10.7619/jcmp.201813016
    [4]ZHANG Qing, GAO Changjun. Expression of T lymphocyte subsets, NK cells and B cells in peripheral blood of children with primary immunologic thrombocytopenia[J]. Journal of Clinical Medicine in Practice, 2017, (17): 45-47. DOI: 10.7619/jcmp.201717013
    [6]WU Haijuan. Nursing research on pegaspargase in the treatment of highly invasive lymphoma[J]. Journal of Clinical Medicine in Practice, 2015, (10): 94-96. DOI: 10.7619/jcmp.201510029
    [7]NI Jingyi, CAO Yongfeng, CHEN Jia, CONG Zhirong, XU Xiaohong. Clinical observation of DICE regimen combined with sequential three-dimensional conformal radiotherapy on the treatment of 24 cases of nasal NK/T-cell lymphoma[J]. Journal of Clinical Medicine in Practice, 2012, (23): 36-38.
    [8]QIAO Yan. Efficacy analysis of Xingnaojing injection combined with levorotatory aspartic acid-ornithine on hepatocirrhosis complicated with hepaticencephalopathy[J]. Journal of Clinical Medicine in Practice, 2012, (17): 99-101.
    [9]MA Yong-mei. Clinical observation of BIAsp 30 on type 2 diabetes[J]. Journal of Clinical Medicine in Practice, 2011, (17): 123-125. DOI: 10.3969/j.issn.1672-2353.2011.17.044

  • Cited by

    Periodical cited type(1)

    1. 陈莹，卞杰. 白蛋白紫杉醇或铂类联合信迪利单抗对晚期胃癌血清CA724、CA19-9、PG水平及疗效的影响. 罕少疾病杂志. 2024(11): 93-95 .

    Other cited types(1)

Catalog

    Get Citation
    PDF
    XML
    Article views (516) PDF downloads (23) Cited by(2)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    © 2020 《实用临床医药杂志》编辑部

    Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807

    苏公网安备 32100302010246号

    Supported by: Beijing Renhe Information Technology Co., Ltd.   Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return